{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Corticosteroid+%28OCS%29", "query": { "intervention": "Oral Corticosteroid (OCS)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oral+Corticosteroid+%28OCS%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T16:47:31.317Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06041386", "title": "REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Mepolizumab", "type": "DRUG" }, { "name": "Spirometry", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 336, "start_date": "2024-03-20", "completion_date": "2028-06-14", "has_results": false, "last_update_posted_date": "2025-08-01", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 28, "location_summary": "La Jolla, California • Newport Beach, California • Aurora, Colorado + 24 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06041386" }, { "nct_id": "NCT02336425", "title": "Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QGE031", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 10, "start_date": "2015-09", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2017-08-11", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Kingwood, Texas • Plano, Texas", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Kingwood", "state": "Texas" }, { "city": "Plano", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02336425" }, { "nct_id": "NCT07221838", "title": "A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Generalized Myasthenia Gravis", "gMG" ], "interventions": [ { "name": "Oral Corticosteroid Tapering Schedule", "type": "PROCEDURE" }, { "name": "Ravulizumab", "type": "DRUG" }, { "name": "Prednisone/Prednisolone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-03-04", "completion_date": "2027-08-27", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 5, "location_summary": "Chicago, Illinois • Schaumburg, Illinois • Neptune City, New Jersey + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Schaumburg", "state": "Illinois" }, { "city": "Neptune City", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07221838" }, { "nct_id": "NCT04718389", "title": "A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3511294 (Depemokimab)", "type": "BIOLOGICAL" }, { "name": "Mepolizumab", "type": "BIOLOGICAL" }, { "name": "Benralizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Standard of care (SoC)", "type": "DRUG" }, { "name": "Pre-filled Syringes (PFS)", "type": "DEVICE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1717, "start_date": "2021-01-26", "completion_date": "2025-09-14", "has_results": true, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 119, "location_summary": "Birmingham, Alabama • Scottsboro, Alabama • Litchfield Park, Arizona + 94 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04718389" }, { "nct_id": "NCT02753764", "title": "Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Corticosteroid Resistant (CR) Asthmatics" ], "interventions": [ { "name": "AZD7624", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Jewish Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 2, "start_date": "2017-01", "completion_date": "2019-02-25", "has_results": false, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02753764" }, { "nct_id": "NCT02528214", "title": "Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Oral corticosteroid therapy (prednisone/prednisolone)", "type": "DRUG" }, { "name": "Inhaled corticosteroid (ICS) therapy", "type": "DRUG" }, { "name": "Albuterol/Salbutamol", "type": "DRUG" }, { "name": "Levalbuterol/Levosalbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 210, "start_date": "2015-10-15", "completion_date": "2017-11-13", "has_results": true, "last_update_posted_date": "2019-10-01", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 8, "location_summary": "Los Angeles, California • Rolling Hills Estates, California • St Louis, Missouri + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Amarillo", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02528214" }, { "nct_id": "NCT04206553", "title": "A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Bullous Pemphigoid" ], "interventions": [ { "name": "dupilumab", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "Oral corticosteroids (OCS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 106, "start_date": "2020-10-28", "completion_date": "2025-01-05", "has_results": true, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Redwood City, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Redwood City", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04206553" }, { "nct_id": "NCT02281357", "title": "Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Tralokinumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 140, "start_date": "2015-02-19", "completion_date": "2017-09-07", "has_results": true, "last_update_posted_date": "2019-03-15", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 15, "location_summary": "New Haven, Connecticut • Clearwater, Florida • St Louis, Missouri + 12 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02281357" }, { "nct_id": "NCT01987492", "title": "A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Lebrikizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 230, "start_date": "2014-02-28", "completion_date": "2016-12-20", "has_results": false, "last_update_posted_date": "2017-05-22", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 9, "location_summary": "Bakersfield, California • Long Beach, California • Miami, Florida + 6 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Albany", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01987492" }, { "nct_id": "NCT05061771", "title": "Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bullous Pemphigoid" ], "interventions": [ { "name": "nomacopan (rVA576)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AKARI Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 0, "start_date": "2022-05-06", "completion_date": "2022-08-01", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-09-28T16:47:31.317Z", "location_count": 7, "location_summary": "Los Angeles, California • Skokie, Illinois • Indianapolis, Indiana + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05061771" } ] }